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Table III. Effect of volume on endovascular aneurysm repair (EVAR) outcomes by physician specialty
Variable
Interventional radiologist Interventional cardiologist General surgeon Cardiothoracic surgeon Vascular surgeon
Low volume Low volume Low volume Low volume Low volume High volume
Bleeding, % 4.6 2.8 1.9 3.1 3.7 2.9
Stroke, % 0.3 0.0 0.0 3.1 0.3 0.1
Cardiac, % 1.6 1.4 0.0 9.4 2.0 2.1
Respiratory, % 0.0 0.0 0.0 0.0 0.6 0.1
Vascular, % 0.3 0.7 0.0 3.1 1.0 0.7
SSI, % 0.3 0.0 0.0 0.0 0.4 0.1
Other, % 1.3 0.0 0.0 0.0 0.8 0.5
Length of stay, days 4.0 6 4.9 3.2 6 3.5 4.5 6 10.6 5.4 6 7.0 3.8 6 7.6 3.5 6 2.0
Costs $32,858 $33,599 $33,274 $25,801 $32,130 $31,950
Mortality, % 1.3 0.7 7.4 6.3 2.4 2.7
SSI, Surgical site infection.
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Aneurysms Does Not Independently Reduce Long-Term
Mortality Compared With Open Repair
William P. Robinson, MD, Andres Schanzer, MD, Francesco Aiello, MD,
Julie Flahive, MS, Danielle R. Doucet, MD, Jessica P. Simons, MD,
MPH, Elias Arous, MD, Louis M. Messina, MD. University of
Massachusetts Medical School, Worcester, Mass
Objectives: Endovascular repair (EVAR) of ruptured abdominal
aortic aneurysms (RAAAs) reduces in-hospital mortality compared with
open repair (OR) but it is unknown whether EVAR reduces long-term mor-
tality. We hypothesized that EVAR of RAAA would independently reduce
long-term mortality compared with OR.
Methods: The Vascular Quality Initiative (VQI) database (2003-
2013) was used to determine Kaplan-Meier 1-year and 5-year mortality after
EVAR and OR of RAAA. Multivariate analysis was performed to identify pa-
tient and operative characteristics associated with mortality at 1 and 5 years
after RAAA repair.
Results: Among 590 patients who underwent EVAR and 692 patients
who underwent OR of RAAA, the lower mortality seen in-hospital after
EVAR (EVAR: 23% vs OR: 35%; P < .001) persisted at 1 year (EVAR: 34%
vs OR: 42%; P ¼ .001) and 5 years (EVAR: 50% vs OR: 58%; P ¼ .003;
Fig) after repair. After adjusting for patient and operative characteristics,
EVAR did not independently reduce mortality at 1 year (hazard ratio [HR],
0.88 [95% conﬁdence interval, 0.7-1.1]) or 5 years (HR, 0.95 [.77-1.2])
compared with OR. Women (HR, 1.3 [1.04-1.6]), age (HR, 1.06 [1.05-
1.08] per 5 years), homeoxygenuse (HR, 1.9 [1.3-2.7]), dialysis-dependence
(HR, 3.9 [1.8-8.6]), cardiac ejection fraction<50% (HR, 1.5 [1.03-2.1]), as
well as preoperative systolic blood pressure<90mmHg (HR, 1.4 [1.1-1.8]),
loss of consciousness (HR, 1.7 [1.3-2.2]), and cardiac arrest (HR, 3.4Fig. Long-term survival after open and endovascular repair of ruptured
abdominal aortic aneurysm.[2.5-4.5]) on admission predicted mortality at 1 and 5 years after RAAA
repair. Type I endoleak (HR, 2.2 [1.2-3.8]) also predictedmortality at 1 year.
Conclusions: EVAR does not independently reduce long-term mor-
tality compared with OR. Patient comorbidities and indices of shock on
admission are the primary independent determinants of long-term mortality.
However, the lower early mortality observed in the VQI for patients
selected to undergo EVAR of RAAA compared with patients selected for
OR is sustained over time, supporting the use of EVAR for RAAA in appro-
priate candidates. Better elucidation of the key selection factors, including
aneurysm anatomy, is needed to best select patients for EVAR and OR in
order to reduce long-term mortality.
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Objectives: Our aim was to examine the predictive value of the
Anatomic Severity Grading (ASG) score on aortic branch vessel complica-
tions, nonaortic adverse events, and survival.
Methods: Using three-dimensional reconstruction of preoperative
computed tomography angiography imaging (TeraRecon; Aquarius iNtui-
tionWorkstation, Foster City, Calif), we retrospectively reviewed endovascu-
lar aneurysm repairs (EVARs) from 2009 to 2012. Two independent patient
groups were created based on ASG score: <14 (low-score group) and $14
(high-score group). Aortic branch vessel complications, nonaortic adverse
events, and survival were collected and analyzed in relation to ASG score.
Results: We analyzed 218 patients. Mean age was 74 years (range, 48-
92), 75% were male and 83% were Caucasian; 114 were in the low-score
group and 104 were in the high-score group. Excluding age, there were no
other differences in demographics between groups. There were 17 patients
with 30-day aortic branch vessel complications: claudication or rest pain
(50%), renal insufﬁciency (39%), and spinal or mesenteric ischemia (11%).
The incidence of 30-day branch vessel complications was signiﬁcantly
different between the low-score group (n¼ 5 [4%]) and the high score group
(n ¼ 12 [11%]; P ¼ .049). There were 23 patients with 30-day nonaortic
adverse events: pulmonary dysfunction (46%), coagulopathy (32%), deep
vein thrombosis (DVT; 14%), myocardial infarction (4%), and cerebrovascu-
lar accident (CVA; 4%). The incidence of 30-day nonaortic adverse events
trended toward statistical signiﬁcance when analyzing the low-score group
(n ¼ 8 [7%]) vs the high-score group (n ¼ 15 [14%]; P ¼ .075). When we
combined 30-day aortic branch vessel complications with 30-day nonaortic
adverse events, we found that the low-score group was statistically different
from the high-score group (n ¼ 10 [9%] vs n ¼ 23 [22%]; P ¼ .006). After
30 days, 40 patients hadmidterm aortic branch complications and 41 patients
had nonaortic adverse events. After Kaplan-Meier analysis, the freedom from
adverse events was statistically different at 1 year (80% vs 71%) and 2 years
(79% vs 65%; P¼ .006). Lastly, Kaplan-Meier analysis revealed a signiﬁcantly
longer survival in the low-score group (93% and 90% at 1 and 4 years) vs the
high-score group (88% and 80% at 1 and 4 years; P ¼ .022).
Conclusions: The abdominal aortic aneurysmASG score can be used not
only to predict operative complexity and reinterventions but also 30-day and
midtermaorticbranchvessel complications, nonaortic adverseevents, and survival.
